SELLAS Life Sciences Group, Inc. — Director's Dealing 2014

Jul 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2014-06-30

Reporting Person: SCHWARTZ MARK W. (EVP, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-30	Common Stock	J	2461	$2.6	Acquired	412126	Direct

Footnotes

F1: Pursuant to the Issuer's Employee Stock Purchase Plan.